疏肝解郁方治疗肝郁气滞型勃起功能障碍临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R277.5

基金项目:

深圳市中医重点专科建设项目(2019-2023年);广东省中医药局“十三五”中医重点专科建设项目


Clinical Study on Shugan Jieyu Prescription for Erectile Dysfunction of Liver Depression and Qi Stagnation Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察疏肝解郁方治疗肝郁气滞型勃起功能障碍(ED) 的临床疗效。方法:选取90 例ED患者,按随机数字表法分为试验组及对照组各45 例,其中对照组脱落2 例,共完成88 例。试验组服用疏肝解郁方治疗,对照组服用枸橼酸西地那非片治疗。2 组均用药8 周。比较2 组治疗4 周、8 周后国际勃起功能指数(IIEF-5) 评分(包括问题3、问题4 评分)、中医证候评分、焦虑自评量表(SAS) 评分的变化,观察2 组临床疗效及不良反应发生情况。结果:治疗4 周、8 周后,2 组IIEF-5 中问题3、问题4 评分均较治疗前上升,试验组上述2 项评分均高于同一时间段对照组,差异有统计学意义(P<0.05)。治疗4 周、8 周后,2 组IIEF-5 评分均较治疗前上升,试验组IIEF-5 评分均高于同一时间段对照组,差异有统计学意义(P<0.05)。治疗后,2 组中医证候评分中性欲减退、情志抑郁、腹胀不适、大便溏薄评分均较治疗前下降,治疗8 周后,试验组中医证候各项评分均低于对照组,差异有统计学意义(P<0.05)。治疗4 周、8 周后,2 组SAS 评分均较治疗前下降(P<0.05),试验组SAS 评分均低于同一时间段对照组(P<0.05)。经Ridit 分析,试验组临床疗效优于对照组,差异有统计学意义(P<0.05)。2 组在治疗过程中未出现明显不良反应。结论:疏肝解郁方可缓解肝郁气滞型ED 患者的临床症状,使勃起功能得到改善,缓解焦虑等不良情绪。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Shugan Jieyu Prescription for erectile dysfunction (ED) of liver depression and qi stagnation type. Methods:A total of 90 cases of ED patients were selected and divided into the trial group and the control group according to the random number table method,with 45 cases in each group. Two cases dropped out from the control group. The trial group was treated with Shugan Jieyu Prescription, and the control group was treated with Sildenafil Citrate Tablets. The administration lasted for eight weeks. The changes of Internation Index of Erectile Function(IIEF- 5) scores including question 3 and question 4, Chinese medicine syndrome scores and Self- rating Anxiety Scale (SAS) after four and eight weeks of treatment were compared between the two groups. The clinical effects and the incidence of adverse reactions in the two groups were observed. Results: After four and eight weeks of treatment, scores of question 3 and 4 in IIEF- 5 in the two groups were increased when compared with those before treatment,and the two scores in the trial group were higher than those in the control group in the same period,the difference being significant(P<0.05). After four and eight weeks of treatment,IIEF-5 scores in the two groups were increased when compared with those before treatment, and the IIEF-5 scores in the trial group were higher than those in the control group in the same period,the difference being significant(P<0.05). After treatment, traditional Chinese medicine(TCM) scores of decreased sexual desire,emotional depression,abdominal distension,and loose stool in the two groups were decreased when compared with those before treatment;after eight weeks of treatment,each TCM syndrome score in the trial group was lower than that in the control group,the difference being significant (P<0.05). After four and eight weeks of treatment,SAS scores in the two groups were decreased when compared with those before treatment(P<0.05),and SAS score in the trial group was lower than that in the control group in the same period(P<0.05). According to Ridit analysis,the clinical effect in the trial group was better than that in the control group,the difference being significant(P<0.05). There was no obvious adverse reaction in the two groups during the treatment. Conclusion:Shugan Jieyu Prescription has effects in relieving clinical symptoms of ED patients of liver depression and qi stagnation type, improving their erectile function and allaying anxiety and other negative emotions.

    参考文献
    相似文献
    引证文献
引用本文

陈慰填,龚碧贞,周文彬,洪志明,曾杨玲.疏肝解郁方治疗肝郁气滞型勃起功能障碍临床研究[J].新中医,2022,54(21):114-117

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-11-15
  • 出版日期:
文章二维码